Status:
COMPLETED
An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
New York City Health and Hospitals Corporation
Conditions:
Potentially Inappropriate Medications
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study will assess whether a modification in the default dose and frequency (the first option a provider sees) during electronic prescribing of a high-risk drug can impact prescribing behavior and...
Eligibility Criteria
Inclusion
- a patient must be hospitalized
- 65-years old or older
- receive one of the targeted medications
Exclusion
- \- none
Key Trial Info
Start Date :
February 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2022
Estimated Enrollment :
8640 Patients enrolled
Trial Details
Trial ID
NCT05218343
Start Date
February 16 2022
End Date
August 2 2022
Last Update
March 17 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
NYC Health+Hospitals
New York, New York, United States, 10013
2
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029